These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9014457

  • 1. [Analysis of Parkinson's disease and related syndromes using 123I-IMP-SPECT with the ARG method].
    Kageyama H, Kikuchi S, Tashiro K.
    Nihon Rinsho; 1997 Jan; 55(1):238-42. PubMed ID: 9014457
    [Abstract] [Full Text] [Related]

  • 2. [Statistic rCBF study of extrapyramidal disorders].
    Kamei H, Nakajima T, Fukuhara N.
    No To Shinkei; 2002 Aug; 54(8):667-72. PubMed ID: 12355877
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of Parkinson's disease using 123I-IMP SPECT].
    Hayashi H, Odano I, Nishihara M, Higuchi S, Sakai K, Ishikawa A.
    Kaku Igaku; 1989 Nov; 26(11):1405-15. PubMed ID: 2615027
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cerebral perfusion in progressive supranuclear palsy.
    Johnson KA, Sperling RA, Holman BL, Nagel JS, Growdon JH.
    J Nucl Med; 1992 May; 33(5):704-9. PubMed ID: 1569479
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.
    Asahina M, Suhara T, Shinotoh H, Inoue O, Suzuki K, Hattori T.
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):155-63. PubMed ID: 9703164
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease.
    Defebvre L, Lecouffe P, Destée A, Houdart P, Steinling M.
    Acta Neurol Scand; 1995 Sep; 92(3):235-41. PubMed ID: 7484078
    [Abstract] [Full Text] [Related]

  • 17. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
    Brücke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wöber C, Müller C, Podreka I.
    J Neural Transm Suppl; 1997 Sep; 50():9-24. PubMed ID: 9120429
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P, Sławek J, Derejko M, Dubaniewicz M.
    Neurol Neurochir Pol; 2003 Sep; 37 Suppl 5():263-74. PubMed ID: 15098354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.